GLOBAL MEDICAL REIT INC (GMRE) Stock Analyst Ratings
USA - NYSE:GMRE - US37954A3032 - REIT
31.8 USD
+1.65 (+5.47%)
31.8 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 80% to GMRE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 43.48. This target is 36.72% above the current price.
GMRE was analyzed by 16 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about GMRE.
In the previous month the buy percentage consensus was at a similar level.
GMRE was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-13 | JMP Securities | Upgrade | Market Perform -> Market Outperform |
| 2025-05-08 | Baird | Maintains | Neutral -> Neutral |
| 2025-03-12 | Citizens Capital Markets | Reiterate | Market Perform -> Market Perform |
| 2024-10-18 | Berenberg | Initiate | Buy |
| 2024-09-19 | Alliance Global Partners | Initiate | Buy |
| 2024-05-13 | B. Riley Securities | Maintains | Buy -> Buy |
| 2023-05-08 | B. Riley Securities | Maintains | Buy |
| 2023-03-06 | B. Riley Securities | Maintains | Buy |
| 2022-10-10 | Baird | Downgrade | Outperform -> Neutral |
| 2022-10-06 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2022-01-13 | Keybanc | Downgrade | Overweight -> Sector Weight |
| 2021-09-20 | Keybanc | Initiate | Overweight |
| 2021-07-09 | Colliers Securities | Initiate | Buy |
| 2021-04-16 | BMO Capital | Initiate | Outperform |
GLOBAL MEDICAL REIT INC / GMRE FAQ
What do analysts expect the price target to be for GLOBAL MEDICAL REIT INC (GMRE)?
16 analysts have analysed GMRE and the average price target is 43.48 USD. This implies a price increase of 36.72% is expected in the next year compared to the current price of 31.8.
Can you provide the consensus rating for GLOBAL MEDICAL REIT INC stock?
The consensus rating for GLOBAL MEDICAL REIT INC (GMRE) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.